{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:54:27Z","timestamp":1767592467185,"version":"3.48.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ck0106765h0003"],"award-info":[{"award-number":["24ck0106765h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japanese Association of Dermatologic Surgery"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10147-025-02936-6","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T02:51:22Z","timestamp":1764903082000},"page":"214-222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic outcomes of immediate complete lymph node dissection versus observation in patients with acral melanoma of the sole with sentinel node metastasis: a retrospective, multicenter study"],"prefix":"10.1007","volume":"31","author":[{"given":"Sadao","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ichigozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Kiniwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayuri","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Takai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiichi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kuwatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Funakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Inozume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Takenouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiraku","family":"Kokubu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusaku","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyasu","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichiro","family":"Ishizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Iino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Uchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoe","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Inafuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Haga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahide","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Hoashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Hiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Asagoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utsugi","family":"Iwasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Kadono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohito","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichiro","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Uhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Komori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Igawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3664-5818","authenticated-orcid":false,"given":"Yasuhiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"4","key":"2936_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/archdermatol.2008.609","volume":"145","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Goldstein AM, McMaster ML et al (2009) Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol 145(4):427\u2013434. https:\/\/doi.org\/10.1001\/archdermatol.2008.609","journal-title":"Arch Dermatol"},{"key":"2936_CR2","unstructured":"Network NCC (2025) Melanoma: cutaneous. NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae) Version 2.2025"},{"issue":"7","key":"2936_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ et al (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370(7):599\u2013609. https:\/\/doi.org\/10.1056\/NEJMoa1310460","journal-title":"N Engl J Med"},{"issue":"23","key":"2936_CR4","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ et al (2017) Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med 376(23):2211\u20132222. https:\/\/doi.org\/10.1056\/NEJMoa1613210","journal-title":"N Engl J Med"},{"issue":"32","key":"2936_CR5","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1200\/JCO.18.02306","volume":"37","author":"U Leiter","year":"2019","unstructured":"Leiter U, Stadler R, Mauch C et al (2019) Final analysis of DeCOG-SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node. J Clin Oncol 37(32):3000\u20133008. https:\/\/doi.org\/10.1200\/JCO.18.02306","journal-title":"J Clin Oncol"},{"issue":"8","key":"2936_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/ced.13243","volume":"42","author":"A Desai","year":"2017","unstructured":"Desai A, Ugorji R, Khachemoune A (2017) Acral melanoma foot lesions. Part 1: epidemiology, aetiology, and molecular pathology. Clin Exp Dermatol 42(8):845\u2013848. https:\/\/doi.org\/10.1111\/ced.13243","journal-title":"Clin Exp Dermatol"},{"key":"2936_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-025-02747-9","author":"Y Fujisawa","year":"2025","unstructured":"Fujisawa Y, Yoshikawa S, Takenouchi T et al (2025) Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma study. Int J Clin Oncol. https:\/\/doi.org\/10.1007\/s10147-025-02747-9","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"2936_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1365-2230.2004.01644.x","volume":"29","author":"NM Luk","year":"2004","unstructured":"Luk NM, Ho LC, Choi CL et al (2004) Clinicopathological features and prognostic factors of cutaneous melanoma among Hong Kong Chinese. Clin Exp Dermatol 29(6):600\u2013604. https:\/\/doi.org\/10.1111\/j.1365-2230.2004.01644.x","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"2936_CR9","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/jamadermatol.2013.5853","volume":"149","author":"HJ Jung","year":"2013","unstructured":"Jung HJ, Kweon SS, Lee JB et al (2013) A clinicopathologic analysis of 177 acral melanomas in Koreans: relevance of spreading pattern and physical stress. JAMA Dermatol 149(11):1281\u20131288. https:\/\/doi.org\/10.1001\/jamadermatol.2013.5853","journal-title":"JAMA Dermatol"},{"issue":"6","key":"2936_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/00008390-200412000-00016","volume":"14","author":"JW Chang","year":"2004","unstructured":"Chang JW, Yeh KY, Wang CH et al (2004) Malignant melanoma in Taiwan: a prognostic study of 181 cases. Melanoma Res 14(6):537\u2013541. https:\/\/doi.org\/10.1097\/00008390-200412000-00016","journal-title":"Melanoma Res"},{"key":"2936_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030468","author":"ER Nadelmann","year":"2025","unstructured":"Nadelmann ER, Singh AK, Abbruzzese M et al (2025) Acral melanoma in skin of color: current insights and future directions: a narrative review. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers17030468","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2936_CR12","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/jnci\/djz005","volume":"111","author":"I Yeh","year":"2019","unstructured":"Yeh I, Jorgenson E, Shen L et al (2019) Targeted genomic profiling of acral melanoma. J Natl Cancer Inst 111(10):1068\u20131077. https:\/\/doi.org\/10.1093\/jnci\/djz005","journal-title":"J Natl Cancer Inst"},{"key":"2936_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115356","volume":"220","author":"S Reinhard","year":"2025","unstructured":"Reinhard S, Utikal JS, Zaremba A et al (2025) First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: a multicenter study from the prospective skin cancer registry ADOREG. Eur J Cancer 220:115356. https:\/\/doi.org\/10.1016\/j.ejca.2025.115356","journal-title":"Eur J Cancer"},{"key":"2936_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-025-02399-5","author":"Z Hosseinpour","year":"2025","unstructured":"Hosseinpour Z, Anari R, Kassir M et al (2025) Trends in melanoma prevalence and risk factors by skin reactions to sun exposure in the U.S. population (1999\u20132018). J Racial Ethn Health Disparities. https:\/\/doi.org\/10.1007\/s40615-025-02399-5","journal-title":"J Racial Ethn Health Disparities"},{"issue":"7653","key":"2936_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward NK, Wilmott JS, Waddell N et al (2017) Whole-genome landscapes of major melanoma subtypes. Nature 545(7653):175\u2013180. https:\/\/doi.org\/10.1038\/nature22071","journal-title":"Nature"},{"key":"2936_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076710","author":"C Moeckel","year":"2023","unstructured":"Moeckel C, Bakhl K, Georgakopoulos-Soares I et al (2023) The efficacy of tumor mutation burden as a biomarker of response to immune checkpoint inhibitors. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24076710","journal-title":"Int J Mol Sci"},{"issue":"25","key":"2936_CR17","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan M, Hopkins A, Jaffee EM (2017) Tumor mutational burden and response rate to PD-1 inhibition. N Engl J Med 377(25):2500\u20132501. https:\/\/doi.org\/10.1056\/NEJMc1713444","journal-title":"N Engl J Med"},{"issue":"1","key":"2936_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0479-7","volume":"6","author":"S Maleki Vareki","year":"2018","unstructured":"Maleki Vareki S (2018) High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors. J Immunother Cancer 6(1):157. https:\/\/doi.org\/10.1186\/s40425-018-0479-7","journal-title":"J Immunother Cancer"},{"key":"2936_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.748674","volume":"13","author":"B Ning","year":"2022","unstructured":"Ning B, Liu Y, Wang M et al (2022) The predictive value of tumor mutation burden on clinical efficacy of immune checkpoint inhibitors in melanoma: a systematic review and meta-analysis. Front Pharmacol 13:748674. https:\/\/doi.org\/10.3389\/fphar.2022.748674","journal-title":"Front Pharmacol"},{"issue":"2","key":"2936_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jdin.2020.07.004","volume":"1","author":"BM Tod","year":"2020","unstructured":"Tod BM, Schneider JW, Bowcock AM et al (2020) The tumor genetics of acral melanoma: What should a dermatologist know? JAAD Int 1(2):135\u2013147. https:\/\/doi.org\/10.1016\/j.jdin.2020.07.004","journal-title":"JAAD Int"},{"issue":"7","key":"2936_CR21","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1007\/s10238-023-01107-z","volume":"23","author":"J Zhong","year":"2023","unstructured":"Zhong J, Zou Z, Hu T et al (2023) Survival impact of immediate complete lymph node dissection for Chinese acral and cutaneous melanoma with micrometastasis in sentinel nodes: a retrospective study. Clin Exp Med 23(7):4003\u20134010. https:\/\/doi.org\/10.1007\/s10238-023-01107-z","journal-title":"Clin Exp Med"},{"issue":"6","key":"2936_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/pcmr.13113","volume":"36","author":"CC Hsu","year":"2023","unstructured":"Hsu CC, Liao YH, Sheen YS (2023) Survival benefit of sentinel lymph node biopsy in Asian melanoma patients. Pigment Cell Melanoma Res 36(6):522\u2013530. https:\/\/doi.org\/10.1111\/pcmr.13113","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"2936_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl 48(3):452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transpl"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02936-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02936-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02936-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:51:26Z","timestamp":1767592286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02936-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2936"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02936-6","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Naoya Yamazaki has received research funding from Bristol-Myers Squibb (BMS), Merck Sharp & Dohme (MSD), Novartis, Ono Pharma, and Takara Bio, and has served as a consultant and\/or received honoraria from BMS, MSD, Novartis, and Ono Pharma. Shigeto Matsushita has received honoraria from BMS, MSD, Novartis, and Ono Pharma. Yasuhiro Nakamura has received research funding and served as a consultant and\/or received honoraria from Alexion Pharma, Bristol-Myers Squibb, Dai-ichi Sankyo, HUYA Bioscience International, Kyowa Kirin, LEO Pharma, Maruho, MSD, Novartis, Ono Pharma, Pierre Fabre, Sanofi, Sun Pharma, and Tanabe-Mitsubishi Pharma. Sadao Inoue has received honoraria from Maruho. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was approved by the Institutional Review Board of Saitama Medical University International Medical Center (IRB No. 2023-022). The requirement for informed consent was waived due to the retrospective nature of the study and use of anonymized data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}